News
Sep 17,2021
Wanhuida Partner speaks at China Pharma IP Summit 2021
From September 16 to 17, 2021, the “Sixth China Pharma
IP Summit 2021”, which is jointly organized by YIP Events and IP ForeFront,
is held at Grand Hyatt Shanghai.
The summit, which themes “New Kinetic Energy
Stimulates New Vitality”, features informative workshops and thought-provoking
group discussions, encompassing topics including “Anti-monopoly and
enforcement of active pharmaceutical ingredients in China”, “IP
Protection dilemma of biomedical companies and administrative protection route”, “Punitive damages regime”, “Challenges, opportunities and
countermeasures of domestic generic drug enterprises in China”, “Supplementary
experimental data: acceptance criteria, analysis of practical cases and trends”, “Early resolution mechanism of drug patent disputes: exclusive period,
waiting period, procedural issues”, “Drug patent term compensation regime”, “R&D trends and patent prospects of the frontier medicine: ADC drugs,
dual/polyclonal antibody drugs, PROTAC technology”, among others.
Tang Tiejun, Partner of Wanhuida Intellectual Property
speaks in the panel discussion on the “Pitfalls in the implementation of early
resolution mechanism of drug patent disputes”. Ms. Tang shares insights with
regards to the characteristics of China’s early resolution mechanism of drug
patent disputes, the impact of centralized procurement on the operation of such
mechanism as well as the possible scenarios in the context of double-track enforcement
regime.
Fellow panelists include Shen Dongmin, ex- senior
director of CSPC Pharmaceutical Group Co., Ltd., Dou Xiarui, IP Director, Yangtze
River Pharmaceutical Group, among others. The panel discussion is moderated by Cheng
Yongshun, Director of Beijing Intellectual Property Institute.
The firm’s Partners Wang Rui and Xie Minnan also attend
the summit.
The event brings together more than 500 attendees,
including leading in-house IP counsels, patent prosecutors and litigators,
government officials and policy experts from around the world, sharing their
insights on how to navigate seismic changes in both regulatory and IP landscape
and business community. The event is also live streamed to nearly 400
audiences.
Opening ceremony
Panel discussion (Tang Tiejun, second from left)
Tang Tiejun
Attendees